Ama-Platelet awaphazamiseki ngisho nangama-dose anconywe izikhathi ezingu-6 ze-osteoarthritis
Lesi sihloko siyingxenye ye- Arthritis Archives.
Idatha: February 20, 2000
Ama-platelets awaphazanyiswa yi-Celebrex
Iziphumo ezivela ocwaningweni olulawulwa yi-double-blind, randomized, ne-placebo eshicilelwe encwadini ka-February 2000 ye-Journal of Clinical Pharmacology yembula ukuthi i-arthritis ethandwa kakhulu yi- Celebrex (celecoxib) ayiphazamisi umsebenzi weplatelet ngisho nangama-1200 mg / ngosuku.
Umthamo we-1200 mg / ngosuku empeleni izikhathi eziyisithupha eziphakanyisiwe zokunqunywa kwe-Celebrex enqunyelwe ukwelashwa kwe- osteoarthritis.
Kungani lokhu kutholakala kokugcina umsebenzi weplatelet evamile kubaluleke kangaka? Kubalulekile:
- Iziguli ezisengozini yokuphuma kwegazi.
- Iziguli ezithatha imithi eyandisa ingozi yokuphuma kwamanzi.
- Abantu abane-arthritis ethatha i-aspirin ye-dose ephansi nge-cardiovascular disease prophylaxis.
Mayelana NeSifundo
Inhloso yocwaningo kwakuwukuqhathanisa imiphumela yezindleko eziphakeme kakhulu ze-Celebrex ekutheni ukwelashwa kwe- naproxen kumaplatelet .
- I-Celebrex yi- COX-2 inhibitor ekhethiwe.
- I-Naproxen iyi-NSAID engakhethi (isidakamizwa esingafuni ukuvuvukala).
Ngesikhathi sezinsuku ezingu-10, abahlanganyeli bokutadisha banikezwa ngezikhathi ezithile ukulinganisa okuhlukile koku:
- I-celebrex
- naproxen
- i-placebo
Izikhathi zokuphuza zazisetshenziselwa ukukala umsebenzi weplatelet. Ngokuphambene noCelebrex noma i-placebo, i-naproxen yafakazela ukunciphisa ama-platelet aggregation nokwandisa izikhathi zokuphuma kwegazi.
Iqiniso lokuthi i-Celebrex ayizange iphazamise i-platelet aggregation evamile ukuqinisekiswa okwengeziwe kwe-COX-2 ukukhethwa kwezidakamizwa nokuphepha kwayo.
I-osteoarthritis Nezifo Zezinhliziyo
Ngokuvamile i-osteoarthritis nezifo zenhliziyo zenzeka ndawonye kubantu asebekhulile. I-CDC (Izikhungo Zokulawula Nokuvimbela Izifo) inqume ukuthi abantu abadala kwabangu-1 e-United States bane-hypertension futhi abantu abangaba ngu-1 kwabangu-3 abane-hypertension nabo bane-arthritis.
Cishe umuntu oyedwa kwabayisihlanu abangaphezu kweminyaka engama-35 ubudala athatha i- aspirin njengesilinganiso sokuvimbela isifo senhliziyo. Imiphumela yokutadisha ukusekela i-Celebrex njengendlela yokukhetha abantu abanesidingo se-aspirin ephansi.
Izinsiza ezihlobene
- I-celebrex (i-celecoxib)
- I-osteoarthritis
- I-COX-2 Inhibitors Ekhethiwe
- Okuningi mayelana NSAIDs
Umthombo: Journal of Clinical Pharmacology, February 16, 2000, MedscapeWire
Ishicilelwe okokuqala: 02/20/2000